Enterome: First Biomarkers, Next Stop Drug Discovery?
By Marie Powers
Monday, April 23, 2012
Changes to the human gut microbiota are linked to serious diseases such as ulcerative colitis and Crohn's disease. While evidence has implicated disruptions to the homeostasis of the gut microbiome as playing a role in inflammatory bowel diseases, treatments aimed at reshaping the microbial content have failed to induce stable, long-term improvements in bacterial diversity.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.